» Articles » PMID: 18166598

Complex Chronic Comorbidities of COPD

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2008 Jan 2
PMID 18166598
Citations 196
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic obstructive pulmonary disease (COPD) is defined by fixed airflow limitation associated with an abnormal pulmonary and systemic inflammatory response of the lungs to cigarette smoke. The systemic inflammation induced by smoking may also cause chronic heart failure, metabolic syndrome and other chronic diseases, which may contribute to the clinical manifestations and natural history of COPD. Thus COPD can no longer be considered a disease only of the lungs, as it is often associated with a wide variety of systemic consequences. A better understanding of the origin and consequences of systemic inflammation, and of potential therapies, will most likely lead to better care of patients with COPD. Medical textbooks and clinical guidelines still largely ignore the fact that COPD seldom occurs in isolation. As the diagnosis and assessment of severity of COPD may be greatly affected by the presence of comorbid conditions, the current authors believe that lung function measurement, noninvasive assessment of cardiovascular and metabolic functions, and circulating inflammatory markers (e.g. C-reactive protein) might help to better characterise these patients. Similarly, preventive and therapeutic interventions should address the patient in their complexity.

Citing Articles

Prevalence and Correlates of Osteoporosis and Metabolic Syndrome Among Patients With Chronic Obstructive Pulmonary Disease at a Rural Tertiary Healthcare Center in India.

Roy R, Kumar A Cureus. 2025; 17(2):e78759.

PMID: 40070633 PMC: 11894770. DOI: 10.7759/cureus.78759.


A service evaluation following the implementation of computer guided consultation software to support primary care reviews for chronic obstructive pulmonary disease.

Chakrabarti B, McKnight E, Pearson M, Dowie L, Richards J, Choudhury-Iqbal M NPJ Prim Care Respir Med. 2025; 35(1):12.

PMID: 40069195 PMC: 11897336. DOI: 10.1038/s41533-025-00421-1.


Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024.

Hellings P, Conti D, Bertels X, Backer V, Brusselle G, De Corso E Front Allergy. 2025; 6:1540499.

PMID: 40065834 PMC: 11891202. DOI: 10.3389/falgy.2025.1540499.


MicroRNAs as promising drug delivery target to ameliorate chronic obstructive pulmonary disease using nano-carriers: a comprehensive review.

Khanna V, Singh K Mol Cell Biochem. 2024; 480(3):1431-1448.

PMID: 39254870 DOI: 10.1007/s11010-024-05110-0.


Physiological analyses of swallowing changes due to chronic obstructive pulmonary disease in anesthetized male rats.

Nagoya K, Tsujimura T, Yoshihara M, Watanabe M, Magara J, Kawasaki K Front Physiol. 2024; 15:1445336.

PMID: 39170764 PMC: 11337103. DOI: 10.3389/fphys.2024.1445336.